fluoxymesterone has been researched along with tamoxifen in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (57.14) | 18.7374 |
| 1990's | 10 (28.57) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bull, JM; Lippman, ME; Myers, CE; Simon, RM; Tormey, DC | 1 |
| Falkson, CI; Falkson, G; Gelman, RS; Glick, J; Harris, J | 1 |
| Abe, K | 1 |
| Falkson, CI; Falkson, G; Gelman, R; Glick, J; Harris, J | 2 |
| Bellocq, JP; Chambon, P; Edgerton, SM; Koerner, FC; Rio, MC; Sawicka, JM; Schwartz, LH; Thor, AD | 1 |
| Cullinan, SA; Gerstner, JG; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Schaid, DJ; Tschetter, LK; Twito, DI; Windschitl, HE | 1 |
| Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC | 1 |
| Adachi, I; Watanabe, T | 1 |
| Andersen, J; Poulsen, HS | 1 |
| Bagley, C; Lippman, ME; Steinberg, SM; Swain, SM | 1 |
| Cullinan, SA; Gerstner, JG; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Marschke, RF; Schaid, DJ; Twito, DI; Windschitl, HE | 1 |
| Chang, AY; Davis, TE; Falkson, G; Falkson, HC; Loprinzi, CL; Rasmussen, P; Tormey, DC | 1 |
| Kamby, C; Rose, C | 1 |
| Gennatas, CS; Kalovidouris, A; Kouvaris, J; Papavasiliou, C; Paraskevas, GA; Trichopoulos, D | 1 |
| Hashizume, Y; Hirano, M; Ishida, K; Iwa, T; Katada, S; Kawaura, Y; Yamada, T | 1 |
| Bloom, ND; Brigati, DJ; Carter, AC; Degenshein, GA; Gaetjens, E; Pertschuk, LP; Tobin, EH | 1 |
| Miura, S; Yoshida, M | 1 |
| Bezwoda, WR; Browde, S; Derman, DP; Goss, G; Lange, M | 1 |
| Murayama, Y | 1 |
| Rubens, RD; Steiner, R; Stewart, JF | 1 |
| Cassidy, JG; Edwards, BK; Lippman, ME; Tormey, DC | 1 |
| Westerberg, H | 1 |
| Forrest, AP; Gunn, JM; Hamilton, T; Langlands, AO; McFadyen, IJ; Roberts, MM; Stewart, HJ | 1 |
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Leuenberger, U; Ryssel, HJ; Sonntag, RW | 1 |
| Arafah, BM; Manni, A; Pearson, OH | 1 |
| Abeloff, MD; Falkson, G; Falkson, HC; Gilchrist, K; Gray, R; Tormey, DC | 1 |
| Falkson, G; Gilchrist, KW; Neuberg, D; Olson, JE; Pandya, KJ; Richter, MP; Solin, LJ; Tormey, DC; Veeder, M | 1 |
| Chang, AY; Falkson, G; Gelman, R; Harris, J; Pandya, KJ; Putt, M; Tormey, DC | 1 |
| Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
| Abeloff, M; Falkson, G; Hu, P; Sledge, GW; Tormey, D | 1 |
| Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C | 1 |
| Bernardo, MV; Harrington, DP | 1 |
| Donohue, JH; Goetz, MP; Ingle, JN; Krook, JE; Kugler, JW; Mailliard, JA; Michalak, JC; Perez, EA; Pisansky, TM; Suman, VJ; Wold, LE | 1 |
2 review(s) available for fluoxymesterone and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
23 trial(s) available for fluoxymesterone and tamoxifen
| Article | Year |
|---|---|
Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Stilbenes; Tamoxifen | 1976 |
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Middle Aged; Mitolactol; Multivariate Analysis; Prognosis; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 1991 |
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Receptors, Estrogen; Remission Induction; Survival Rate; Tamoxifen; Weight Gain | 1991 |
[Role of supporting therapy of Juzentaiho-to (JTT) in advanced breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxymesterone; Humans; Leukopenia; Middle Aged; Quality of Life; Random Allocation; Tamoxifen; Thrombocytopenia | 1989 |
Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Danazol; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1988 |
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1988 |
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Clinical Laboratory Techniques; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Prognosis; Prospective Studies; Random Allocation; Tamoxifen; Vincristine | 1986 |
Metastatic pattern and response to endocrine therapy in human breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Medroxyprogesterone; Menopause; Neoplasm Metastasis; Tamoxifen | 1986 |
A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Fluoxymesterone; Humans; Hydrocortisone; Middle Aged; Random Allocation; Tamoxifen | 1987 |
[Internal endocrine therapy of breast cancer].
Topics: Androstanols; Breast Neoplasms; Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Testosterone | 1984 |
Results of endocrine therapy do not predict response to chemotherapy in advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Diethylstilbestrol; Doxorubicin; Ethinyl Estradiol; Female; Fluoxymesterone; Humans; Middle Aged; Prednisolone; Tamoxifen; Vincristine | 1983 |
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.
Topics: Adult; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Tamoxifen | 1983 |
Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.
Topics: Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Fluoxymesterone; Humans; Menopause; Tamoxifen; Time Factors | 1980 |
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Diethylstilbestrol; Double-Blind Method; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1980 |
Combination hormonotherapy with tamoxifen and fluoxymesterone in patients with advanced breast cancer relapsing on hormonotherapy.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluoxymesterone; Humans; Middle Aged; Tamoxifen | 1982 |
Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Logistic Models; Middle Aged; Mitolactol; Neoplasm Metastasis; Remission Induction; Survival Analysis; Tamoxifen; Treatment Outcome; Vincristine | 1994 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Fluoxymesterone; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Receptors, Estrogen; Survival Rate; Tamoxifen; Thiotepa; Vinblastine | 1993 |
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Recurrence; Survival Analysis; Tamoxifen | 1997 |
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Fluoxymesterone; Humans; Methotrexate; Middle Aged; Mitolactol; Neoplasm Metastasis; Pilot Projects; Remission Induction; Survival Analysis; Tamoxifen; Vincristine | 1998 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Tamoxifen; Treatment Outcome | 2000 |
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluoxymesterone; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Tamoxifen | 2006 |
10 other study(ies) available for fluoxymesterone and tamoxifen
| Article | Year |
|---|---|
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Humans; Methotrexate; Mitolactol; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1992 |
pS2 expression and response to hormonal therapy in patients with advanced breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluoxymesterone; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 1991 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Leucovorin; Leukopenia; Lung; Methotrexate; Mitolactol; Neoplasm Metastasis; Prednisone; Receptors, Estrogen; Tamoxifen; Thrombocytopenia; Time Factors; Vincristine | 1985 |
Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diethylstilbestrol; Female; Fluoxymesterone; Humans; Immunohistochemistry; Menopause; Middle Aged; Neoplasm Recurrence, Local; Paraffin; Receptors, Estrogen; Survival Analysis; Tamoxifen | 1989 |
[Treatment of chemo-endocrine therapy in recurrent breast cancer].
Topics: Adult; Androstanols; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Fluoxymesterone; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovariectomy; Tamoxifen | 1986 |
Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.
Topics: Adrenalectomy; Binding, Competitive; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Castration; Centrifugation, Density Gradient; Diethylstilbestrol; Female; Fluorescent Antibody Technique; Fluoxymesterone; Histocytochemistry; Humans; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1980 |
Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Menopause; Methotrexate; Tamoxifen; Time Factors | 1984 |
[Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Topics: Breast Neoplasms; Castration; Diethylstilbestrol; Estradiol; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Tamoxifen | 1984 |
Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer.
Topics: Breast Neoplasms; Drug Administration Schedule; Female; Fluoxymesterone; Humans; Hypophysectomy; Neoplasm Metastasis; Tamoxifen; Time Factors | 1981 |
Sample size calculations for the two-sample problem using the multiplicative intensity model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Fluoxymesterone; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Likelihood Functions; Markov Chains; Methotrexate; Models, Biological; Prednisone; Randomized Controlled Trials as Topic; Sample Size; Tamoxifen | 2001 |